The view
As of 13 November 2026, Veeva Systems closed at $301.53, a price change of +1.5% over the past year, yet the close sits 103.7% above its low of that year after a sharp rebound. The Intrinsic Value model puts the company at $109.22 per share, a gap of −63.8% against the price, so the price stands well above intrinsic value. The published 21-session view leans barely up, at +0.22%. The published 63-session view leans slightly down, at −0.34%.
Next month: why the model view is positive
The 21-session view leans up only at the margin, at +0.22%, and the published probability of a rise is just 23%, so the lean rests on a skewed band from −17.1% to +17.5% rather than on broad conviction. The upside facts are strong momentum and strength against the sector, with the close +41.2% from its long-term average. Weighing against it, many chart-pattern measures of price, volume and momentum sit at the highest of the company's own five years, and the regime is strong risk-off. Across 200 past situations like today's, the median move over the next 21 sessions was +1.6%, with 56% rising. That history agrees with the slight upward lean, though it is history, not a forecast.
Next 3 months: model view negative
The 63-session view leans slightly down, at −0.34%, inside a wide band from −25.2% to +24.5%. It points the other way from the 21-session view. That can happen when a short burst of momentum supports the next few weeks while a price stretched far above its long-term average, with chart-pattern readings at five-year extremes, tends to give back ground over a longer stretch. The past situations disagree with this lean: over the next 63 sessions their median return was +6%, and 63% of them rose. That record is history, not a forecast, and it was matched on only seven measures.
The long term
The long-term case is mixed. Intrinsic value of $109.22 sits far below the price, a gap of −63.8%, and the value family ranks among the lower part of the S&P 500. Against its sector the multiple looks middling, with a price-to-earnings of 33.36 at percentile 53, and price-to-book stands at 4.44. Operating quality is solid: return on equity of 14.4%, revenue growth of +17.6% and operating cash flow of $1.67B, with balance-sheet health at the highest of its own five years. The Piotroski score of 3 is weak, though. Past situations like today's showed a median of +15% over the following year, with 72% rising, which is history, not a forecast. Valuation drives the cautious side; growth and cash flow drive the steadier side.
How sure we are
The 21-session view deserves limited weight. On Veeva Systems, 41% of 283 matured 21-session forecasts matched the direction, below the base rate of about half across all names. The bands are wide, from −17.1% to +17.5% over 21 sessions and from −25.2% to +24.5% over 63 sessions, so the small expected moves sit inside large uncertainty. The past situations rest on 200 cases, a reasonable sample, but they were matched on seven measures, not on the 568 features computed today, so they offer context rather than confirmation for the longer horizons.